Omega Healthcare Named UiPath AI25 Award Winner at UiPath FORWARD

MUMBAI, India, Oct. 24, 2024 /PRNewswire/ -- UiPath (NYSE: PATH), a leading enterprise automation and AI software company, announced that it is transforming operations for Omega Healthcare, a global leader in revenue cycle management, healthcare and clinical enablement services, through AI-powered automation.

Omega Healthcare was named an UiPath AI25 Award Winner at UiPath FORWARD, UiPath annual gathering of global AI and automation experts. The annual award program identifies the 25 most innovative UiPath customers using a combination of AI and automation as a strategic change enabler to accelerate bigger and bolder outcomes.

NEW YORK, Aug. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UiPath, Inc. (NYSE: PATH).

Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/uipath-loss-submission-form-2/?id=96011&from=4

NEW YORK, Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

RADNOR, Pa., Aug. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against UiPath, Inc. ("UiPath") (NYSE: PATH). The action charges UiPath with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of UiPath's materially misleading statements and omissions to the public, UiPath's investors have suffered significant losses. The lead plaintiff deadline is August 19, 2024.

NEW YORK, Aug. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UiPath investors who were adversely affected by alleged securities fraud between December 1, 2023 and May 29, 2024. Follow the link below to get more information and be contacted by a member of our team:

NEW YORK, Aug. 15, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UiPath, Inc. (NYSE: PATH).

Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/uipath-loss-submission-form-2/?id=95549&from=4

BENSALEM, Pa., Aug. 14, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UiPath Inc. ("UiPath" or the "Company") (NYSE: PATH).

Class Period: December 1, 2023 – May 29, 2024Lead Plaintiff Deadline: August 19, 2024

Investors suffering losses on their UiPath investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 215-638-4847 or by email to howardsmith@howardsmithlaw.com.

LOS ANGELES, Aug. 14, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UiPath Inc. ("UiPath" or "the Company") (NYSE: PATH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between December 1, 2023 and May 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 19, 2024.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In UiPath To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 in UiPath between December 1, 2023 and May 29, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/PATH.

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UiPath investors who were adversely affected by alleged securities fraud between December 1, 2023 and May 29, 2024. Follow the link below to get more information and be contacted by a member of our team:

NEW YORK,, Aug. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UiPath, Inc. (NYSE: PATH).

Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/uipath-loss-submission-form-2/?id=94751&from=4

RADNOR, Pa., Aug. 9, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against UiPath, Inc. ("UiPath") (NYSE: PATH). The action charges UiPath with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of UiPath's materially misleading statements and omissions to the public, UiPath's investors have suffered significant losses. The lead plaintiff deadline is August 19, 2024.

LOS ANGELES, Aug. 9, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UiPath Inc. ("UiPath" or the "Company") (NYSE: PATH).

Class Period: December 1, 2023 – May 29, 2024

Lead Plaintiff Deadline: August 19, 2024

If you wish to serve as lead plaintiff of the UiPath lawsuit, you can submit your contact information at www.glancylaw.com/cases/UiPath-Inc-1/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UiPath investors who were adversely affected by alleged securities fraud between December 1, 2023 and May 29, 2024. Follow the link below to get more information and be contacted by a member of our team:

NEW YORK, Aug. 8, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UiPath, Inc. (NYSE: PATH).

Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/uipath-loss-submission-form-2/?id=94273&from=4

LOS ANGELES, July 25, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against UiPath Inc. ("UiPath" or "the Company") (NYSE:PATH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PATH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

NEW YORK, July 24, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against UiPath, Inc. ("UiPath" or the "Company")(NYSE: PATH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

RADNOR, Pa., July 24, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against UiPath, Inc. ("UiPath") (NYSE: PATH). The action charges UiPath with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of UiPath's materially misleading statements and omissions to the public, UiPath's investors have suffered significant losses. The lead plaintiff deadline is August 19, 2024.

LOS ANGELES, July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UiPath Inc. ("UiPath" or "the Company") (NYSE: PATH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between December 1, 2023 and May 29, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 19, 2024.